Abstract
In the present study we investigated the effect of the non-alcoholic fatty liver disease (NAFLD) on the alterations in the activity of neurotransmitters catabolizing enzymes and energy catabolising enzymes, prooxidants, endogenous antioxidants and proinflammatory cytokines in brain tissue of NAFLD rats. Rats were intraperitonealy injected with CCl4 solution at a dose of (0.021 mole/Kg, 20 μL, body weight) three times weekly for four weeks. Acetylcholine esterase (AChE), monoamine oxidase (MAO), prooxidant/ antioxidants status, ATPase, lipid profile and glucose level were estimated spectrophotometrically while inflammatory markers; interleukin 6 and tumor necrosis factor alpha (IL6 and TNF-α) and insulin were assessed by ELISA technique. Our results showed that the induced NAFLD and insulin resistance (IR) were accompanied with hyperglycemia and hyperlipidemia and lowered brain glucose level with elevated ATPase activity, prooxidant status (TBARS level, xanthine oxidase and cytochrome 2E1 activities), and inflammatory markers. Through the induction period AChE activity was significantly increased compared to control in blood, liver and brain tissues. Also, MAO activity was significantly increased in both brain and liver tissue but decreased in serum compared with control. These biochemical data were supported with pathophysiological analysis that showed severe neurodegeneration, pyknosis acuolations and cavitations. These observations warrant the reassessment of the conventional concept that the NAFLD with IR progression may induce disturbances in activities of neurotransmitters catabolising enzymes and energy production accompanied with oxidative stress and metabolic disorders, acting as relative risk factors for brain dysfunction and damage with the development of age-associated neurodegenerative diseases such as Alzheimer's disease.
Similar content being viewed by others
References
Ahboucha S, Butterworth R (2008) The neurosteriod system: implication in the pathophysiology of hepatic eccephalopathy. Neurochem Int 52:575–585
Aleynik S, Leo M, Aleynik M, Leiber C (1997) Polyenyphosphatidylcholine prevents carbon tetrachloride induced lipid peroxidation while it attenuates liver fibrosis. J Hepatol 27:554–556
Anania FA, Parekh S (2007) Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease. Gastroenterology 132:2191–2207
Angelini N, Rafacho A, Boschero AC, Bosqueiro JR (2010) Involvement of the cholinergic pathway in glucocorticoid-induced hyperinsulinemia in rats. Diabetes Res Clin Pract 87:184–191
Angulo P (2007) GI epidemiology: nonalcoholic fatty liver disease: incidence and prevalence. Aliment Pharmacol Ther 25(8):883–889
Banks WA (2004) The source of cerebral insulin. Eur J Pharmacol 490:5–12
Bardov VG, Shmuter GM, Suchkov BP, Stepanenko GA, Khalavchuk IV, Gerashchenko SK, Kapelist VA (1990) The effect of a complex of preventive agents on the level of radioactive cesium and strontium in the bodies of laboratory animals (white rats). Gig Sanit 10:51–52
Baura GD, Foster DM, Kaiyala K, Porte D, Kahn E, Schwartz W (1996) Insulin transport from plasma into the central nervous system is inhibited by dexamethasone in dogs. Diabetes 45(1):86–90
Beal M (2005) Mitochondria take centre stage in aging and neurodegeneration. Ann Neurol 58:495–505
Biessels GJ, Kappalle LJ (2005) Uhrecht Diabetic Encephalopathy Study Group: Increased risk of Alzheimer’s disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology? Biochem Soc Trans 33:1041–1044
Bingham E, Hopkins D, Smith D, Pernet A, Hallett W, Reed L (2002) The role of insulin in human brain glucose metabolism: an fluoro-deoxyglucose positron emission tomography study. Diabetes 51(12):3384–3390
Bosetti F, Brizzi F, Barogia S, Mancuso M, Siciliano G, Tendi E, Murric L, Rapoport S, Solaini G (2002) Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer’s disease. Neurobiol Aging 23:371–376
Browning JD, Horton JD (2004) Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114:147–152
Cai D, Yuan M, Frantz DF et al (2005) Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 11:183–190
Calabrese V, Scapagnini G, Giuffrida-Stella A, Bates T, Clark J (2001) Mitochondrial involvement in brain function and dysfunction: relevance to aging, neurodegenerative disorders and longevity. Neurochem Res 26:739–764
Candeiasa F, Abreub P, Pereiraa A, Cruz-Morais J (2009) Effects of strictosamide on mouse brain and kidney Na+, K+−ATPase and Mg2+−ATPase activities. J Ethnopharmacology 121:117–122
Cao Q, Mak KM, Lieber CS (2005) Cytochrome P4502E1 primes macrophages to increase TNF-_ production in response to lipopolysaccharide. Am J Physiol Gastrointest Liver Physiol 289:G95–G107
Caro A, Evans L, Cederbaum I (2009) CYP2E1 overexpression inhibits microsomal Ca2+−ATPase activity in HepG2 cells. Toxicology 255:171–176
Chavez JA, Summers SA (2003) Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes. Arch Biochem Biophys 419:101–109
Choudhary P, Malik V, Puri S, Ahluwalia P (1996) Studies on the effects of monosodium glutamate on hepatic microsomal lipid peroxidation, calcium, ascorbic acid and glutathione and its dependent enzymes in adult male mice. Toxicol Lett 89:71–76
Cibickova L, Hyspler R, Micuda S, Cibicek N, Jun D, Ticha A, Brcakova E, Palicka V, Zivna H (2009) The influence of simvastatin, atorvastatin and high-cholesterol diet on acetylcholinesterase activity, amyloid beta and cholesterol synthesis in rat brain. Steroids 74:13–19
Craft S (2005) Insulin resistance syndrome and Alzheimer’s disease: age- and obesity-related effects on memory, amyloid, and inflammation. Neurobiol Aging 26:65–69
Craft S, Watson G (2004) Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol 3(3):169–178
Craft S, Asthana S, Newcomer JW, Wilkinson CW, Matos IT, Baker LD et al (1999) Enhancement of memory in Alzheimer’s disease with insulin and somatostatin, but not glucose. Arch Gen Psychiatry 56:1135–1140
Day CP, James OF (1998) Steatohepatitis: a tale of two “hits”? Gastroenterology 114:842–845
De Luis DA, Aller R, Izaola O et al (2008) Effect of a hypocaloric diet in transaminases in nonalcoholic fatty liver disease and obese patients, relation with insulin resistance. Diabetes Res Clin Pract 79:74–78
Diehl AM (2002) Nonalcoholic steatosis and steatohepatitis IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines. Am J Physiol Gastrointest Liver Physiol 282:G1–G5
Drake H, Goss H, Wood G (1979) New convenient method for the rapid analysis of inorganic pyrophosphate. Anal Biochem 94:117–120
Eckel RH, Grundy SM, Zimmet PZ (2005) The metabolic syndrome. Lancet 365:1415–1428
Ellman G, Courtney K, Andres V, Featherstone R (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95
Emery MG, Fisher JM, Chien JY et al (2003) CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease. Hepatology 38:428–435
Farrell GC, Larter CZ (2006) Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43:S99–S112
Fossati P, Prencipe L (1982) Triglyceride determination calorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 28:2077–2080
Fowler J, Volkow N, Wang G, Pappas N, Logan J, Mac Gregor R, Alexoff D, Wolf A, Warner D, Cilento R, Zezulkova I (1998) Neuropharmacological action of cigarette smoke: brain monoamine oxidase B (MAOB) inhibition. J Addict Dis 17:23–34
Ghareeb D, Hussein H (2008) Vanadium improves brain acetylcholinesterase activity on early stage alloxan-diabetic rats. Neurosci Lett 436:44–47
Ghareeb D, Hussein H, Khalil A, El-Saadani M, Ali A (2010a) Toxic effects of lead exposure on the brain of rats: Involvement of oxidative stress, inflammation, acetylcholinesterase, and the beneficial role of flaxseed extract. Toxicol Environ Chem 92(1):187–195
Ghareeb D, Khalil A, Elbassoumy A, Hussien H, Abo-Sraiaa M (2010b) Ameliorated effects of garlic (Allium sativum) on biomarkers of subchronic acrylamide hepatotoxicity and brain toxicity in rats. Toxicol Environ Chem 92(7):1357–1372
Halliwell B, Gutteridge J (2000) Free radicals in biology and medicine. In: (ed) Oxford University Press, pp 148–149
Hare M (1928) Tyramine oxidase. I. A new enzyme system in liver. Biochem J 22(4):968–979
Hattori N, Kitagawa K, Higashida K, Yagyu K, Shimoham S, Watay T, Perry G, Smith M, Inagaki C (1998) Cl-ATPase and Na/K-ATPase activities in Alzheimer’s disease brains. Neurosci Lett 254:141–144
Hjelm M, De Verdier C (1963) Determination of serum glucose by glucose oxidase method. Scand J Clin Lab Invest 15:415–428
Hsu C, Guo L (2002) Antioxidant nutrients and lead toxicity. Toxicology 180(1):33–44
Hu W, Gray NW, Brimijoin S (2003) Amyloid-beta increases acetylcholinesterase expression in neuroblastoma cells by reducing enzyme degradation. J Neurochem 86:470–478
Hummel S, Fischer A, Martin S, Schafer F, Buettner G (2006) Nitric oxide as a cellular antioxidant: a little goes a long way. Free Radic Biol Med 40:501–506
Hwang JH, Stein DT, Barzilai N, Cui MH, Tonelli J, Kishore P, Hawkins M (2007) Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies. Am J Physiol Endocrinol Metab 293:E1663–E1669
Institute of Laboratory Animal Resources (1996) Guide for the care and use of laboratory animals. Commission on life sciences, national research council. National Academy, Washington, DC
Johansen M, Bak L, Schousboe A, Iversen P, Keiding S, Sorensen M, Vilstrup H, Gjedde A, Ott P, Waagepetersen H (2007) The metabolic role of isoleucine in detoxification of ammonia in cultured mouse neurons and astrocytes. Neurochem Int 50:1042–1051
Jollow D, Mitchell J, Zampaglione N, Gillette J (1974) Bromobenze induced liver necrosis: protective role of glutathione and evidence for 3, 4-bromobenzenoxide as the hepatotoxic intermediate. Pharmacology 11:151–169
Korenblat KM, Fabbrini E, Mohammed BS, Klein S (2008) Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology 134:1369–1375
Lam H, Yeh C, Cheng K, Hus C, Cheng J (2008) Effect of cholinergic denervation on hepatic fibrosis induced by carbon tetrachloride in rats. Neuroscience Lett 438:90–95
Litwack G, Bothwell JW, Williams JN, Elvehjem J (1953) A colorimetric assay for xanthine oxidase in rat liver homogenates. J Biol Chem 200:303–310
Macdonald GA, Bridle KR, Ward PJ et al (2001) Lipid peroxidation in hepatic steatosis is associated with hepatic fibrosis and occurs predominantly in acinar zone 3. J Gastroenterol Hepatol 16:599–606
Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N, Rizzetto M (2003) Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37:917–923
McCullough AJ (2004) The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis 8:VIII521–VIII533
McGarry JD (2002) Dys-regulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51:7–18
McGarry JD, Dobbins RL (1999) Fatty acids, lipotoxicity and insulin secretion. Diabetologia 42:128–138
Meyer JH, Ginovart N, Boovariwala A, Sagrati S, Hussey D, Garcia A, Young T, Praschak-Rieder N, Wilson AA, Houle S (2006) Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. Arch Gen Psychiatry 63(11):1209–1216
Montgomery H, Dymock J (1961) The determination of nitrite in water. Analyst 35:414–416
Musso G, Gambino R, Cassader M (2009) Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog Lipid Res 48:1–26
Neuschwander-Tetri BA, Brunt EM, Wehmeier KR et al (2003) Interim results of a pilot study demonstrating the early effects of the PPAR-g ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis. J Hepatol 38:434–440
Ott A, Stolk RP, Hofman A, van Harskamp F, Grobbee DE, Breteler MM (1999) Association of diabetes mellitus and dementia: The Rotterdam study. Diabetologia 39:1392–1397
Paglia E, Valentine N (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158–169
Perez-Carreras M, Del Hoyo P, Martin MA et al (2003) Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 38:999–1007
Pessayre D, Mansouri A, Fromenty B (2002) Nonalcoholic steatosis and steatohepatitis: mitochondrial dysfunction in steatohepatitis. Am J Physiol Gastrointest Liver Physiol 282:G193–G199
Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI (2005) Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 54:603–608
Plomgaard P, Bouzakri K, Krogh-Madsen R et al (2005) Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes 54:2939–2945
Plummer D (1978) Amino acids and proteins. In: (ed) An introduction to practical biochemistry. UK, McGraw- Hill Book Co, pp 145–146
Reddy JK (2001) Nonalcoholic steatosis and steatohepatitis: peroxisomal β-oxidation, PPAR-α and steatohepatitis. Am J Physiol Gastrointest Liver Physiol 281:G1333–G1339
Reger MA, Watson GS, Green PS, Wilkinson CW, Baker LD, Cholerton B et al (2008) Intranasal insulin improves cognition and modulates β-amyloid in early AD. Neurology 70(6):440–448
Robertson GR, Leclercq I, Farrell GC (2001) Nonalcoholic steatosis and steatohepatitis: cytochrome P-450 enzymes and oxidative stress. Am J Physiol Gastrointest Liver Physiol 281:G1135–G1139
Robin M, Sauvage I, Grandperret T, Descatoire V, Pessayre D, Fromenty B (2005) Ethanol increases mitochondrial cytochrome P450 2E1 in mouse liver and rat hepatocytes. FESB Lett 579:6895–6902
Rojo L, Sjöberg MK, Hernández P, Zambrano C, Maccioni RB (2006) Roles of cholesterol and lipids in the etiopathogenesis of Alzheimer’s disease. J Biomed Biotechnol 3:73–90
Samuel VT, Liu ZX, Qu X, Elder BD, Bilz S, Befroy D, Romanelli AJ, Shulman GI (2004) Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem 279:32345–32353
Samuel VT, Liu ZX, Wang A, Beddow SA, Geisler JG, Kahn M, Zhang XM, Monia BP, Bhanot S, Shulman GI (2007) Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease. J Clin Invest 117:739–745
Sandler M, Reveley M, Glover V (1981) Human platelet monoamine oxidase activity in health and disease: a review. J Clin Pathol 34:292–302
Sanyal AJ, Campbell-Sargent C, Mirshahi F et al (2001) Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120:1183–1192
Schildkraut JJ, Herzog JM, Orsulak PJ, Edelman SE, Shein HM, Frazier SHSH (1976) Reduced platelet monoamine oxidase activity in a subgroup of schizophrenic patients. Am J Psychiatry 133(4):438–440
Seki S, Kitada T, Yamada T, Sakagushi H, Nakatani K, Wakasa K (2002) In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J Hepatol 37:56–62
Serviddio G, Sastre J, Bellanti F, Vina J, Vendemiale G, Altomare E (2008) Mitochondrial involvement in non-alcoholic steatohepatitis. Mol Aspects Med 29:22–35
Shoelson SE, Lee J, Goldfine AB (2006) Inflammation and insulin resistance. J Clin Invest 116:1793–1801
Srivastava L, Das N, Sinha S (2002) Quantitative estimation of analytes in blood. In: Srivastava L, Das N, Sinha S (eds) Essential of practical biochemistry. CBS publishers and distributors, New Delhi, pp 91–94
Tokushige K, Takakura M, Tsuchiya-Matsushita N et al (2007) Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis. J Hepatol 46:1104–1110
Valenti L, Fracanzani AL, Dongiovanni P et al (2002) Tumor necrosis factor-alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease. Gastroenterology 122:274–280
Videla LA, Rodrigo R, Orellana M et al (2004) Oxidative stress-related parameters in the liver of nonalcoholic fatty liver disease patients. Clin Sci 106:261–268
Vives-Bauza C, Gonzalo R, Manfredi G, Garcia-Arumi E, Andreu A (2006) Enhanced ROS production and antioxidant defenses in cybrids harbouring mutations in mtDNA. Neurosci Lett 391:136–141
Watson D (1960) A simple method for the determination of serum cholesterol. Clinica Chemica Acta 5:637–643
Watson GS, Craft S (2006) Insulin resistance, inflammation, and cognition in Alzheimer’s Disease:Lessons for multiple sclerosis. J Neurol Sci 245:21–33
Weber L, Boll M, Stampfl A (2003) Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol 33:105–136
Weltman MD, Farrell GC, Hall P, Ingelman-Sundberg M, Liddle C (1998) Hepatic cytochrome P450 2E1 is increased in patients with non alcoholic steatohepatitis. Hepatology 28:128–133
Wills ED (1965) Mechanisms of lipid peroxide formation in animal tissues. Biochem J 99(3):667–676
Yu C, Wang F, Jin C, Wu X, Chan W, McKeehan W (2002) Increased carbon tetrachloride-induced liver injury and fibrosis in FGFR4-deficient mice. Am J Pathol 161:2003–2010
Zhao WQ, Alkon DL (2001) Role of insulin and insulin receptor in learning and memory. Mol Cell Endocrinol 177(1–2):125–134
Zheng S, Newton GL, Gonick G, Fahey RC, Ward JF (1988) Radioprotection of DNA by thiols: relationship between the net charge on a thiol and its ability to protect DNA. Radiat Res 114:11–27
Zollner N, Kirsch K (1962) Absorptimetric determination of total lipids in serum. Z Ges Exp Med 135:544–549
Acknowledgements
Special thanks for Prof Dr. Ashraf A. Khalil, protein technology department, the city of scientific research and Application technology, who gave us several advises through the work design.
Competing interests
There is neither financial competing interest (political, personal, religious, ideological, academic, intellectual, commercial or any other) to declare in relation to this manuscript.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Doaa A. Ghareeb and Hani S. Hafez contributed equally to this work
Rights and permissions
About this article
Cite this article
Ghareeb, D.A., Hafez, H.S., Hussien, H.M. et al. Non-alcoholic fatty liver induces insulin resistance and metabolic disorders with development of brain damage and dysfunction. Metab Brain Dis 26, 253–267 (2011). https://doi.org/10.1007/s11011-011-9261-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-011-9261-y